iBio Balance Sheet Health
Financial Health criteria checks 3/6
iBio has a total shareholder equity of $17.8M and total debt of $933.0K, which brings its debt-to-equity ratio to 5.3%. Its total assets and total liabilities are $24.5M and $6.8M respectively.
Key information
5.3%
Debt to equity ratio
US$933.00k
Debt
| Interest coverage ratio | n/a |
| Cash | US$11.04m |
| Equity | US$17.75m |
| Total liabilities | US$6.76m |
| Total assets | US$24.52m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: IBIO's short term assets ($11.7M) exceed its short term liabilities ($3.5M).
Long Term Liabilities: IBIO's short term assets ($11.7M) exceed its long term liabilities ($3.3M).
Debt to Equity History and Analysis
Debt Level: IBIO has more cash than its total debt.
Reducing Debt: IBIO's debt to equity ratio has increased from 0% to 5.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: IBIO has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: IBIO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 11.2% each year